Skip to Content
MilliporeSigma
All Photos(1)

Documents

49963

Sigma-Aldrich

β-tri-Calcium phosphate

puriss. p.a., ≥98% β-phase basis (sintered Powder)

Synonym(s):

β-TCP, β-Tricalcium phosphate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
Ca3O8P2
CAS Number:
7758-87-4
Molecular Weight:
310.18
EC Number:
231-840-8
MDL number:
MFCD00015984
UNSPSC Code:
12352302
PubChem Substance ID:
329757549
NACRES:
NA.55

grade

puriss. p.a.

Quality Level

200

assay

≥98% β-phase basis (sintered Powder)

form

powder

impurities

≤50 mg/kg total heavy metals as lead
≤500 mg/kg total sulfur as SO4 (ICP)

anion traces

chloride (Cl-): ≤50 mg/kg

cation traces

As: ≤0.5 mg/kg
Ba: ≤20 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤10 mg/kg
Cu: ≤5 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤5 mg/kg
Pb: ≤5 mg/kg
Zn: ≤20 mg/kg

InChI

1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6

InChI key

QORWJWZARLRLPR-UHFFFAOYSA-H

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application


  • Tungstosilicic Acid: A Promising Electrolyte for Redox Flow Battery.: This study explores the use of tungstosilicic acid (TSA) as an electrolyte in redox flow batteries (RFB). The research highlights TSA′s high energy density due to its multi-electron transfer capability, making it a promising candidate for enhancing the efficiency and power density of RFBs. This advancement is particularly relevant for large-scale energy storage systems integrating renewable energy technologies (Sharma et al., 2023).

  • Heterogenization of a Tungstosilicic Acid Catalyst for Esterification of Bio-Oil Model Compound.: This paper explores the heterogenization of tungstosilicic acid by supporting it on silica-based materials for the esterification of bio-oil model compounds. The catalyst shows high activity and stability, indicating its potential for industrial applications in bio-oil upgrading (Prasertpong et al., 2022).


Analysis Note

Phase Composition (by XRD analysis):
ß-TCP: >98% ; Hydroxylapatite: <1.0% ; a-TCP: <0%; TTCP: 0%
other Ca-P phases as Calcium pyrophosphate <1.0%

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 4

1 of 4

Hydroxyapatite purum p.a., &#8805;90% (as Ca3(PO4)2, KT)

Sigma-Aldrich

21223

Hydroxyapatite

Tribasic calcium phosphate United States Pharmacopeia (USP) Reference Standard

USP

1087031

Tribasic calcium phosphate

Calcium phosphate, amorphous nanopowder, &lt;150&#160;nm particle size (BET)

Sigma-Aldrich

693871

Calcium phosphate, amorphous

Calcium phosphate tribasic BioReagent, suitable for plant cell culture, powder

Sigma-Aldrich

C3161

Calcium phosphate tribasic

Simon Storgård Jensen et al.
Clinical oral implants research, 17(3), 237-243 (2006-05-05)
The purpose was to qualitatively and quantitatively compare the bone formation and graft resorption of two different bone substitutes used in both orthopedic and oral surgery, with autogenous bone as a positive control. Three standardized bone defects were prepared in
S Yamada et al.
Biomaterials, 18(15), 1037-1041 (1997-08-01)
To study the influence of calcium phosphate ceramic solubility on osteoclastic resorption, neonatal rabbit bone cells were cultured for 2 days on hydroxyapatite (HA), beta-tricalcium phosphate (beta-TCP) and two types of biphasic calcium phosphate (BCP) with HA/beta-TCP ratios of 25/75
Crystal structure analysis of β-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction.
Yashima M, et al.
Journal of Solid State Chemistry, 175(2), 272-277 (2003)
Timo Brandenburger et al.
Shock (Augusta, Ga.), 42(3), 234-238 (2014-07-01)
Remote ischemic preconditioning (RIPC) is an easily applicable method for protecting the heart against a subsequent ischemia and reperfusion (I/R) injury. However, the exact molecular mechanisms underlying RIPC are unknown. We examined the involvement of microRNAs (miRNAs) and in particular
A H Choi et al.
Journal of dental research, 92(10), 853-859 (2013-07-17)
The purpose of coatings on implants is to achieve some or all of the improvements in biocompatibility, bioactivity, and increased protection from the release of harmful or unnecessary metal ions. During the last decade, there has been substantially increased interest
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service